Irisin promotes cardiac progenitor cell‐induced myocardial repair and functional improvement in infarcted heart

Zhao, Yu Tina; Wang, Jianguo; Yano, Naohiro; Zhang, Ling X.; Wang, Hao; Zhang, Shouyan; Qin, Gangjian; Dubielecka, Patrycja M.; Zhuang, Shougang; Liu, Paul Y.; Chin, Y. Eugene; Zhao, Ting C.
February 2019
Journal of Cellular Physiology;Feb2019, Vol. 234 Issue 2, p1671
Academic Journal
Irisin, a newly identified hormone and cardiokine, is critical for modulating body metabolism. New evidence indicates that irisin protects the heart against myocardial ischemic injury. However, whether irisin enhances cardiac progenitor cell (CPC)‐induced cardiac repair remains unknown. This study examines the effect of irisin on CPC‐induced cardiac repair when these cells are introduced into the infarcted myocardium. Nkx2.5+ CPC stable cells were isolated from mouse embryonic stem cells. Nkx2.5 + CPCs (0.5 × 10 6) were reintroduced into the infarcted myocardium using PEGlylated fibrin delivery. The mouse myocardial infarction model was created by permanent ligation of the left anterior descending (LAD) artery. Nkx2.5 + CPCs were pretreated with irisin at a concentration of 5 ng/ml in vitro for 24 hr before transplantation. Myocardial functions were evaluated by echocardiographic measurement. Eight weeks after engraftment, Nkx2.5 + CPCs improved ventricular function as evident by an increase in ejection fraction and fractional shortening. These findings are concomitant with the suppression of cardiac hypertrophy and attenuation of myocardial interstitial fibrosis. Transplantation of Nkx2.5 + CPCs promoted cardiac regeneration and neovascularization, which were increased with the pretreatment of Nkx2.5 + CPCs with irisin. Furthermore, irisin treatment promoted myocyte proliferation as indicated by proliferative markers Ki67 and phosphorylated histone 3 and decreased apoptosis. Additionally, irisin resulted in a marked reduction of histone deacetylase 4 and increased p38 acetylation in cultured CPCs. These results indicate that irisin promoted Nkx2.5 + CPC‐induced cardiac regeneration and functional improvement and that irisin serves as a novel therapeutic approach for stem cells in cardiac repair. These results indicate that Irisin promoted Nkx2.5+ cardiac progenitor cell (CPC)‐induced cardiac regeneration and functional improvement and that Irisin serves as a novel therapeutic approach for stem cells in cardiac repair. MI: myocardial infarction.


Related Articles

  • Human Embryonic Stem Cell-Derived Cardiomyocytes for Heart Therapies. Chung Wah Siu; Moore, Jennifer C.; Li, Ronald A. // Cardiovascular & Haematological Disorders - Drug Targets;Jun2007, Vol. 7 Issue 2, p145 

    Cardiovascular diseases remain the leading cause of mortality and morbidity worldwide. Despite substantial improvements in acute management, survivors of myocardial infarction often progress to heart failure. Since adult cardiomyocytes (CMs) do not regenerate, their loss permanently compromises...

  • Functional Cardiomyocytes Derived from Isl1 Cardiac Progenitors via Bmp4 Stimulation. Cagavi, Esra; Bartulos, Oscar; Suh, Carol Y.; Sun, Baonan; Yue, Zhichao; Jiang, Zhengxin; Yue, Lixia; Qyang, Yibing // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    As heart failure due to myocardial infarction remains a leading cause of morbidity worldwide, cell-based cardiac regenerative therapy using cardiac progenitor cells (CPCs) could provide a potential treatment for the repair of injured myocardium. As adult CPCs may have limitations regarding...

  • Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Laflamme, Michael A.; Chen, Kent Y.; Naumova, Anna V.; Muskheli, Veronica; Fugate, James A.; Dupras, Sarah K.; Reinecke, Hans; Chunhui Xu; Hassanipour, Mohammad; Police, Shailaja; O'Sullivan, Chris; Collins, Lila; Yinhong Chen; Minami, Elina; Gill, Edward A.; Ueno, Shuichi; Chun Yuan; Gold, Joseph; Murry, Charles E. // Nature Biotechnology;Sep2007, Vol. 25 Issue 9, p1015 

    Cardiomyocytes derived from human embryonic stem (hES) cells potentially offer large numbers of cells to facilitate repair of the infarcted heart. However, this approach has been limited by inefficient differentiation of hES cells into cardiomyocytes, insufficient purity of cardiomyocyte...

  • Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction. Zongjin Li; Wilson, Kitchener D.; Smith, Bryan; Kraft, Daniel L.; Fangjun Jia; Mei Huang; Xiaoyan Xie; Robbins, Robert C.; Gambhir, Sanjiv S.; Weissman, Irving L.; Wu, Joseph C. // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Background: Differentiation of human embryonic stem cells into endothelial cells (hESC-ECs) has the potential to provide an unlimited source of cells for novel transplantation therapies of ischemic diseases by supporting angiogenesis and vasculogenesis. However, the endothelial differentiation...

  • Clinical Outcomes of Myocardial Bridging versus No Myocardial Bridging in Patients with Apical Hypertrophic Cardiomyopathy. Zhai, Shan-Shan; Fan, Chao-Mei; An, Shuo-Yan; Hang, Fei; Yang, Yin-Jian; Yan, Li-Rong; Guo, Xi-Ying; Li, Yi-Shi // Cardiology;Mar2018, Vol. 139 Issue 3, p161 

    Objective: To determine the prevalence and clinical effects of myocardial bridging (MB) in patients with apical hypertrophic cardiomyopathy (AHCM). Methods: Angiograms from 212 AHCM patients were reviewed to identify MB. The patients...

  • Tako-tsubo Cardiomyopathy: A Review of the Literature. Dorfman, Todd A.; Aqel, Raed; Mayhew, Marc; Iskandrian, Ami E. // Current Cardiology Reviews;2007, Vol. 3 Issue 2, p137 

    The diagnosis of Takotsubo cardiomyopathy (TC) must be considered in all patients who develop transient left ventricular apical (or mid ventricular) ballooning in the absence of obstructive coronary artery disease (CAD). Although the prevalence of TC remains unknown, approximately 2% of all...

  • Takotsubo cardiomyopathy in a patient undergoing hemodialysis. Takemoto, Fumi; Chihara, Norio; Sawa, Naoki; Hoshino, Junichi; Yamanouchi, Masayuki; Hayami, Noriko; Hasegawa, Eiko; Suwabe, Tatsuya; Nakanishi, Shohei; Nakamura, Michiro; Mitani, Haruo; Ubara, Yoshifumi; Takaichi, Kenmei; Ohno, Minoru // Kidney International;Aug2009, Vol. 76 Issue 4, p467 

    The article presents a medical case of a 61-year-old woman who is hospitalized for cervical spondylosis and who suffered severe chest pain and dyspnea during a hemodialysis session. When she undergone electrocardiography (ECG), results show ST-segment elevation in the precordial leads, and Q...

  • Gemcitabine and Acute Myocardial Infarction. Bdair, Fadi M.; Graham, Susan P.; Smith, Patrick F.; Javie, Milind M. // Angiology;May/Jun2006, Vol. 57 Issue 3, p367 

    The objective of this paper is to report a case of acute, non-q-wave myocardial infarction, presumably secondary to gemcitabine chemotherapy for nonsmall cell lung cancer. A 43-year-old woman with postpartum cardiomyopathy and ischemic heart disease was treated with gemcitabine for metastatic...

  • Improvements in total mortality and lipid levels after acute myocardial infarction in an English health district (1995-1999). Harrop, J; Donnelly, R; Rowbottom, A; Holt, M; Scott, A R // Heart;May2002, Vol. 87 Issue 5, p428 

    Objectives: To quantify changes in 30 day and one year mortality among patients with acute myocardial infarction in southern Derbyshire (population 560 000) in each of five consecutive years (1995-1999) before the publication of the National Service Framework for coronary heart...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics